EMA Panel Backs Combo Drug for Hyperuricemia in Gout Patients

Duzallo contains two medicines in one pill to address both the underelimination and overproduction of uric acid. The FDA approved the drug in August 2017.
International Approvals

https://ift.tt/2tDxHNG